What Is GHK-Cu?
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide first identified in human plasma. Its concentration declines with age, and this observation has driven extensive preclinical research into its biological roles, particularly in dermatological and tissue remodeling models.
Collagen and Extracellular Matrix Research
In vitro studies have investigated GHK-Cu for its effects on fibroblast activity, including collagen I, collagen III, and elastin gene expression. Research has demonstrated upregulation of genes associated with extracellular matrix (ECM) production and remodeling, including tissue inhibitors of metalloproteinases (TIMPs) and decorin.
Wound Healing Models
Preclinical wound healing research has explored GHK-Cu's effects on multiple phases of repair, including inflammation modulation, angiogenesis, fibroblast recruitment, and matrix deposition. Animal wound models have been used to investigate closure rates, tensile strength, and histological outcomes.
Antioxidant and Anti-Inflammatory Pathways
GHK-Cu has been investigated in cellular models for antioxidant properties, including superoxide dismutase (SOD) upregulation, iron chelation, and modulation of oxidative stress markers. Anti-inflammatory effects have been explored through measurement of cytokine production, NF-κB signaling, and inflammatory cell recruitment in preclinical models.
Research Applications
Explore ROEHN's GHK-Cu for your dermatological and tissue remodeling research, complemented by BPC-157 for comprehensive regenerative investigation.
Research Disclaimer
This article is for educational and informational purposes only. All compounds discussed are intended strictly for in-vitro and preclinical research use. They are not intended for human consumption. Always consult published scientific literature and institutional review protocols before initiating any research program.